Company: NIVFW
Filing Date: 2025-08-22
Form Type: DRS
Source: 0001213900-25-079717
Chunk: 52

Company: NewGenIvf Group Ltd
Filing Date: 2025-08-22
Form: DRS
Chunk 52
---
 and NewGenIvf’s client base may not grow at the same rates they historically
have, or they may decline in the future. NewGenIvf’s future growth will depend, in part, on its ability to:

| ● | continue to attract new clients and/or maintain existing clients; |

| ● | price its solutions and services effectively so that it is able to attract new clients, expand sales to its existing clients and maintain profitability; |

| ● | provide its clients with client support that meets their needs, including through dedicated PNs; |

| ● | maintain successful collection of applicable receivable balances; |

| ● | retain and maintain relationships with high-quality and respected fertility specialists; |

<div align='center'>29</div>

| ● | attract and retain highly qualified personnel to support all clients; and |

| ● | increase awareness of its brand and successfully compete with other competitors. |

NewGenIvf may not successfully
accomplish all or any of these objectives, which may affect its future revenue, and which makes it difficult for it to forecast its future
results of operations. In addition, if the assumptions that NewGenIvf uses to plan its business are incorrect or change in reaction to
changes in its market, it may be difficult for it to maintain profitability. NewGenIvf’s shareholders should not rely on its revenue
for any prior quarterly or annual periods as any indication of its future revenue or revenue growth.

In addition, NewGenIvf expects
to continue to expend substantial financial and other resources on:

| ● | sales and marketing; |

| ● | technology infrastructure, including systems architecture, scalability, availability, performance and security; and |

| ● | general administration, including increased legal and accounting expenses associated with being a public company. |

These investments may not
result in increased revenue growth in its business. If NewGenIvf is unable to increase its revenue at a rate sufficient to offset the
expected increase in its costs, its business, financial position, and results of operations will be harmed, and NewGenIvf may not be able
to maintain profitability over the long term. Additionally, NewGenIvf may encounter unforeseen operating expenses, difficulties, complications,
delays and other unknown factors that may result in losses in future periods.

If its revenue growth does
not meet its expectations in future periods, NewGenIvf may not maintain profitability in the future, its business, financial position
and results of operations may be harmed.

NewGenIvf’s interim and annual